<?xml version="1.0" encoding="UTF-8"?>
<html xmlns="http://www.w3.org/1999/xhtml">
 <head charset="UTF-8"/>
 <style> * { font-family : helvetica;} .font11 { font-size : 11; } .font12 { font-size : 12; } .font13 { font-size : 13; } .font14 { font-size : 14; } .font15 { font-size : 15; } .font16 { font-size : 16; } .font17 { font-size : 17; } .font18 { font-size : 18; } .font19 { font-size : 19; } .font20 { font-size : 20; } .font21 { font-size : 21; } .font22 { font-size : 22; } .font23 { font-size : 23; } .font24 { font-size : 24; } .font28 { font-size : 28; } .font29 { font-size : 29; } .font31 { font-size : 31; }</style>
 <body>
  <p>
   <span class="font31">IgG </span>
   <span class="font29">HCMV </span>
   <span class="font28">OpenUrl </span>
   <span class="font24">antibodies </span>
   <span class="font23">responses </span>
   <span class="font23">vaccine </span>
   <span class="font23">binding </span>
   <span class="font22">antibody </span>
   <span class="font22">cells </span>
   <span class="font22">gB/MF </span>
   <span class="font21">CrossRef </span>
   <span class="font20">Fig. </span>
   <span class="font20">neutralizing </span>
   <span class="font19">vaccine-elicited </span>
   <span class="font18">&amp;amp;; </span>
   <span class="font18">cell </span>
   <span class="font18">cytomegalovirus </span>
   <span class="font17">AD- </span>
   <span class="font17">vaccinees </span>
   <span class="font17">glycoprotein </span>
   <span class="font17">neutralization </span>
   <span class="font17">infection </span>
   <span class="font17">phagocytosis </span>
   <span class="font16">observed </span>
   <span class="font16">Science </span>
   <span class="font16">robust </span>
   <span class="font16">human </span>
   <span class="font15">infected </span>
   <span class="font15">Domain </span>
   <span class="font15">indicate </span>
   <span class="font15">Web </span>
   <span class="font15">gB-specific </span>
   <span class="font15">non-neutralizing </span>
   <span class="font15">plasma </span>
   <span class="font15">response </span>
   <span class="font14">median </span>
   <span class="font14">virus </span>
   <span class="font14">seropositive </span>
   <span class="font14">elicited </span>
   <span class="font14">including </span>
   <span class="font14">individuals </span>
   <span class="font14">pooled </span>
   <span class="font14">vaccination </span>
   <span class="font14">viral </span>
   <span class="font14">virion </span>
   <span class="font14">Abstract </span>
   <span class="font14">FREE </span>
   <span class="font14">Text </span>
   <span class="font14">assessed </span>
   <span class="font14">data </span>
   <span class="font14">epitope </span>
   <span class="font14">epitopes </span>
   <span class="font14">fluorescent </span>
   <span class="font14">strain </span>
   <span class="font13">HCMV-infected </span>
   <span class="font13">immune </span>
   <span class="font13">mAb </span>
   <span class="font13">target </span>
   <span class="font13">values </span>
   <span class="font13">virions </span>
   <span class="font13">SP=.; </span>
   <span class="font13">control </span>
   <span class="font13">infection. </span>
   <span class="font13">p&amp;lt;;., </span>
   <span class="font13">protein </span>
   <span class="font13">reduced </span>
   <span class="font13">subclass </span>
   <span class="font13">antigenic </span>
   <span class="font13">chronically </span>
   <span class="font13">comparison </span>
   <span class="font13">distinct </span>
   <span class="font13">dotted </span>
   <span class="font13">gB/MF=., </span>
   <span class="font13">magnitude </span>
   <span class="font13">represents </span>
   <span class="font13">(median </span>
   <span class="font13">AD-, </span>
   <span class="font13">ability </span>
   <span class="font13">beads </span>
   <span class="font13">congenital </span>
   <span class="font13">following </span>
   <span class="font13">linear </span>
   <span class="font13">samples </span>
   <span class="font13">test). </span>
   <span class="font12">Furthermore, </span>
   <span class="font12">cytomegalovirus. </span>
   <span class="font12">domain </span>
   <span class="font12">functions </span>
   <span class="font12">infectious </span>
   <span class="font12">mean </span>
   <span class="font12">membrane-associated </span>
   <span class="font12">plots </span>
   <span class="font12">purified </span>
   <span class="font12">seropositive, </span>
   <span class="font12">surface </span>
   <span class="font12">test </span>
   <span class="font12">threshold </span>
   <span class="font12">Towne </span>
   <span class="font12">activity </span>
   <span class="font12">avidity </span>
   <span class="font12">diseases </span>
   <span class="font12">effector </span>
   <span class="font12">experimental </span>
   <span class="font12">group. </span>
   <span class="font12">log </span>
   <span class="font12">new </span>
   <span class="font12">presence </span>
   <span class="font12">role </span>
   <span class="font12">virology </span>
   <span class="font12">(blue </span>
   <span class="font12">(red </span>
   <span class="font12">*=p&amp;lt;;., </span>
   <span class="font12">Additionally, </span>
   <span class="font12">CMV </span>
   <span class="font12">Dom </span>
   <span class="font12">Human </span>
   <span class="font12">assay </span>
   <span class="font12">autologous </span>
   <span class="font12">cluster </span>
   <span class="font12">displayed </span>
   <span class="font12">efficacy </span>
   <span class="font12">gB-binding </span>
   <span class="font12">immunogen </span>
   <span class="font12">likely </span>
   <span class="font12">mediate </span>
   <span class="font12">mediated </span>
   <span class="font12">pathogens </span>
   <span class="font12">point </span>
   <span class="font12">poor </span>
   <span class="font12">protective </span>
   <span class="font12">replicates. </span>
   <span class="font12">site </span>
   <span class="font12">subunit </span>
   <span class="font12">test), </span>
   <span class="font12">uptake </span>
   <span class="font12">using </span>
   <span class="font12">vaccinee </span>
   <span class="font12">women </span>
   <span class="font11">SP=.%; </span>
   <span class="font11">TB/E-infected </span>
   <span class="font11">THP- </span>
   <span class="font11">bound </span>
   <span class="font11">degranulation </span>
   <span class="font11">did </span>
   <span class="font11">expressed </span>
   <span class="font11">gB/MF-elicited </span>
   <span class="font11">high-magnitude </span>
   <span class="font11">identified </span>
   <span class="font11">known </span>
   <span class="font11">lines </span>
   <span class="font11">maternal </span>
   <span class="font11">monocyte </span>
   <span class="font11">region </span>
   <span class="font11">similar </span>
   <span class="font11">transfected </span>
   <span class="font11">women, </span>
   <span class="font11">(E) </span>
   <span class="font11">(Fig. </span>
   <span class="font11">;&amp;lt;;span </span>
   <span class="font11">Black </span>
   <span class="font11">Download </span>
   <span class="font11">Figure </span>
   <span class="font11">HIV- </span>
   <span class="font11">Horizontal </span>
   <span class="font11">III </span>
   <span class="font11">MFI: </span>
   <span class="font11">Mach </span>
   <span class="font11">National </span>
   <span class="font11">Open </span>
   <span class="font11">Saittertherwaite </span>
   <span class="font11">TB/E </span>
   <span class="font11">Vaccine </span>
   <span class="font11">antibodies. </span>
   <span class="font11">antiviral </span>
   <span class="font11">assays </span>
   <span class="font11">bars </span>
   <span class="font11">bind </span>
   <span class="font11">cells. </span>
   <span class="font11">chronic </span>
   <span class="font11">compared </span>
   <span class="font11">correlation </span>
   <span class="font11">data-hide-link-title=""&amp;gt; </span>
   <span class="font11">data-icon-position="" </span>
   <span class="font11">epithelial </span>
   <span class="font11">figure </span>
   <span class="font11">gB/MF=.%, </span>
   <span class="font11">heterologous </span>
   <span class="font11">horizontal </span>
   <span class="font11">important </span>
   <span class="font11">indicates </span>
   <span class="font11">line </span>
   <span class="font11">medicine </span>
   <span class="font11">phagocytosis, </span>
   <span class="font11">positivity </span>
   <span class="font11">protection </span>
   <span class="font11">standard </span>
   <span class="font11">tab </span>
   <span class="font11">value </span>
   <span class="font11">xmlns=";http://www.w.org//xhtml"; </span>
   <span class="font11">Adler </span>
   <span class="font11">Assays </span>
   <span class="font11">Cytomegalovirus </span>
   <span class="font11">Finally, </span>
   <span class="font11">Lastly, </span>
   <span class="font11">Satterthwaite </span>
   <span class="font11">United </span>
   <span class="font11">absence </span>
   <span class="font11">antibody-mediated </span>
   <span class="font11">block </span>
   <span class="font11">cells: </span>
   <span class="font11">clinical </span>
   <span class="font11">complement </span>
   <span class="font11">consists </span>
   <span class="font11">domains </span>
   <span class="font11">elicits </span>
   <span class="font11">examined </span>
   <span class="font11">group </span>
   <span class="font11">indicated </span>
   <span class="font11">infection, </span>
   <span class="font11">mechanism </span>
   <span class="font11">natural </span>
   <span class="font11">open </span>
   <span class="font11">p=., </span>
   <span class="font11">partial </span>
   <span class="font11">peptide </span>
   <span class="font11">phagocytosed </span>
   <span class="font11">phagocytosing </span>
   <span class="font11">positive </span>
   <span class="font11">potent </span>
   <span class="font11">previous </span>
   <span class="font11">profile </span>
   <span class="font11">responses, </span>
   <span class="font11">results </span>
   <span class="font11">single </span>
   <span class="font11">targeted </span>
   <span class="font11">targeting </span>
   <span class="font11">tested </span>
   <span class="font11">titers </span>
   <span class="font11">used </span>
   <span class="font11">vaccines </span>
   <span class="font11">(A) </span>
   <span class="font11">(A,C) </span>
   <span class="font11">(A-D) </span>
   <span class="font11">(C), </span>
   <span class="font11">(D). </span>
   <span class="font11">(F). </span>
   <span class="font11">(I), </span>
   <span class="font11">(J) </span>
   <span class="font11">(Towne </span>
   <span class="font11">(black), </span>
   <span class="font11">(brown). </span>
   <span class="font11">(gB) </span>
   <span class="font11">(green), </span>
   <span class="font11">(mean </span>
   <span class="font11">(purple), </span>
   <span class="font11">ARPE </span>
   <span class="font11">Britt </span>
   <span class="font11">Congenital </span>
   <span class="font11">Dis </span>
   <span class="font11">Glycoprotein </span>
   <span class="font11">Immunol </span>
   <span class="font11">Infect </span>
   <span class="font11">Neutralization </span>
   <span class="font11">New </span>
   <span class="font11">Nonspecific </span>
   <span class="font11">SM- </span>
   <span class="font11">States </span>
   <span class="font11">TRL </span>
   <span class="font11">Thus, </span>
   <span class="font11">Virol </span>
   <span class="font11">adjuvant </span>
   <span class="font11">assess </span>
   <span class="font11">associated </span>
   <span class="font11">based </span>
   <span class="font11">cellular </span>
   <span class="font11">chronically-HCMV </span>
   <span class="font11">chronically-infected </span>
   <span class="font11">circle) </span>
   <span class="font11">circles) </span>
   <span class="font11">combined </span>
   <span class="font11">comparable </span>
   <span class="font11">conducted </span>
   <span class="font11">confirmed </span>
   <span class="font11">construct </span>
   <span class="font11">contrast, </span>
   <span class="font11">corrected. </span>
   <span class="font11">correlated </span>
   <span class="font11">cytodomain </span>
   <span class="font11">cytogam </span>
   <span class="font11">cytosolic </span>
   <span class="font11">demonstrated </span>
   <span class="font11">deviations). </span>
   <span class="font11">dynamic </span>
   <span class="font11">enhancement </span>
   <span class="font11">entry </span>
   <span class="font11">fluorophore-conjugated </span>
   <span class="font11">frequently </span>
   <span class="font11">functional </span>
   <span class="font11">gB-transfected </span>
   <span class="font11">immunization </span>
   <span class="font11">immunogenicity </span>
   <span class="font11">intensity </span>
   <span class="font11">investigated </span>
   <span class="font11">investigation </span>
   <span class="font11">levels </span>
   <span class="font11">limited </span>
   <span class="font11">matrix </span>
   <span class="font11">measured </span>
   <span class="font11">nonspecific </span>
   <span class="font11">phase </span>
   <span class="font11">preimmune </span>
   <span class="font11">reported </span>
   <span class="font11">robust, </span>
   <span class="font11">sera </span>
   <span class="font11">specific </span>
   <span class="font11">square). </span>
   <span class="font11">strains </span>
   <span class="font11">subsequent </span>
   <span class="font11">subtraction </span>
   <span class="font11">symbols) </span>
   <span class="font11">trials. </span>
  </p>
 </body>
</html>
